SynthesisFrontiers in immunology2025

Sacituzumab govitecan as a therapeutic breakthrough in the treatment of triple-negative breast cancer: a systematic review of clinical trials.

Julia Piekarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.